Skip to main content

Table 2 Angiotensinogen gene (AGT) re7079 allele frequencies in the lead-exposed and unexposed (control) population, and the association of these polymorphisms with lead exposure

From: A new model of the mechanism underlying lead poisoning: SNP in miRNA target region influence the AGT expression level

Genotypes

BLL1a (n = 190)

BLL2b (n = 114)

P c

Crude OR (95% CI)

Adjusted OR (95% CI)d

N

%

N

%

rs7079

 CC

100

52.6

76

66.7

0.04

1.00

1.00

 CA

88

46.3

36

31.6

1.86 (1.14–3.03)

2.27 (1.33–3.86)

 AA

2

1.1

2

1.7

0.76 (0.11–5.52)

0.93 (0.12–7.31)

 CA + AA

90

47.4

38

33.3

0.02

1.80 (1.11–2.92)

1.92 (1.16–3.18)

 A Allele

92

24.2

92

17.5

0.08

  
  1. The observed genotype frequency among the control subjects was in agreement with Hardy-Weinberg equilibrium (p2 + 2pq + q2 = 1) 2 = 0.954, P = 0.329 for rs7079
  2. a Blood lead level (BLL) < 200 μg/L
  3. b Blood lead level (BLL) ≥ 400 μg/L
  4. c Two-sided χ2 test for either genotype or allele frequency
  5. d Obtained from logistic regression models adjusted for age, sex, and smoking habits